These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30980925)

  • 1. Impact of EUCAST ceftaroline breakpoint change on the susceptibility of methicillin-resistant Staphylococcus aureus isolates collected from patients with complicated skin and soft-tissue infections.
    Urbán E; Stone GG
    Clin Microbiol Infect; 2019 Nov; 25(11):1429.e1-1429.e4. PubMed ID: 30980925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010).
    Sader HS; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2013 May; 76(1):61-8. PubMed ID: 23535208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates.
    Sader HS; Rhomberg PR; Doyle TB; Flamm RK; Mendes RE
    J Clin Microbiol; 2018 Dec; 56(12):. PubMed ID: 30257898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of MRSA isolates bracketing the current EUCAST ceftaroline-susceptible breakpoint for Staphylococcus aureus: the role of PBP2a in the activity of ceftaroline.
    Lahiri SD; McLaughlin RE; Whiteaker JD; Ambler JE; Alm RA
    J Antimicrob Chemother; 2015 Sep; 70(9):2488-98. PubMed ID: 26045529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicentre study of meticillin-resistant Staphylococcus aureus in acute bacterial skin and skin-structure infections in China: susceptibility to ceftaroline and molecular epidemiology.
    Zhang H; Xiao M; Kong F; O'Sullivan MV; Mao LL; Zhao HR; Zhao Y; Wang H; Xu YC
    Int J Antimicrob Agents; 2015 Apr; 45(4):347-50. PubMed ID: 25649348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial activity of ceftaroline against methicillin-resistant Staphylococcus aureus (MRSA) isolates collected in 2013-2014 at the Geneva University Hospitals.
    Andrey DO; François P; Manzano C; Bonetti EJ; Harbarth S; Schrenzel J; Kelley WL; Renzoni A
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):343-350. PubMed ID: 27744604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftaroline Susceptibility among Isolates of MRSA: A Comparison of EUCAST and CLSI Breakpoints.
    Sachu A
    Ethiop J Health Sci; 2023 Jan; 33(1):143-150. PubMed ID: 36890938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Multicenter Study To Evaluate Ceftaroline Breakpoints: Performance in an Area with High Prevalence of Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Lineage.
    Khan A; Rivas LM; Spencer M; Martinez R; Lam M; Rojas P; Porte L; Silva F; Braun S; Valdivieso F; Mv Lhauser M; Lafourcade M; Miller WR; García P; Arias CA; Munita JM
    J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31315958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of ceftaroline against bacterial pathogens isolated from patients with skin and soft tissue and respiratory tract infections in the Middle East and Africa: AWARE global surveillance programme 2015-2018.
    Karlowsky JA; Hackel MA; Bouchillon SLK; Lowman W; Kotb REM; Mohamed N; Stone GG; Sahm DF
    J Glob Antimicrob Resist; 2021 Mar; 24():249-256. PubMed ID: 33373731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etest® versus broth microdilution for ceftaroline MIC determination with Staphylococcus aureus: results from PREMIUM, a European multicentre study.
    Cantón R; Livermore DM; Morosini MI; Díaz-Regañón J; Rossolini GM;
    J Antimicrob Chemother; 2017 Feb; 72(2):431-436. PubMed ID: 27798220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme.
    Karlowsky JA; Biedenbach DJ; Bouchillon SK; Iaconis JP; Reiszner E; Sahm DF
    J Antimicrob Chemother; 2016 Jan; 71(1):162-9. PubMed ID: 26503667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Activity of Ceftaroline against Staphylococcus aureus Isolated in 2012 from Asia-Pacific Countries as Part of the AWARE Surveillance Program.
    Biedenbach DJ; Alm RA; Lahiri SD; Reiszner E; Hoban DJ; Sahm DF; Bouchillon SK; Ambler JE
    Antimicrob Agents Chemother; 2016 Jan; 60(1):343-7. PubMed ID: 26503659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and antimicrobial susceptibility of bacterial isolates from patients hospitalised with community-acquired skin and skin-structure infection in Europe, Asia and Latin America.
    Sader HS; Streit JM; Carvalhaes CG; Huband MD; Pfaller MA
    J Glob Antimicrob Resist; 2019 Jun; 17():103-108. PubMed ID: 30458298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility testing challenges with ceftaroline, MRSA and a 1 mg/L breakpoint.
    Livermore DM; Mushtaq S; Warner M; James D; Woodford N
    J Antimicrob Chemother; 2015 Dec; 70(12):3259-66. PubMed ID: 26318188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections.
    Das S; Li J; Iaconis J; Zhou D; Stone GG; Yan JL; Melnick D
    J Antimicrob Chemother; 2019 Feb; 74(2):425-431. PubMed ID: 30380060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of clinical isolates of meticillin-resistant Staphylococcus aureus and phenotypic non-extended-spectrum β-lactamase-producing Klebsiella pneumoniae to ceftaroline in Taiwan: Results from Antimicrobial Testing Leadership and Surveillance (ATLAS) in 2012-2018 and Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2018-2019.
    Jean SS; Ko WC; Hsueh PR;
    Int J Antimicrob Agents; 2020 Jul; 56(1):106016. PubMed ID: 32422316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of EUCAST zone diameter breakpoints and quality control range for Staphylococcus aureus with ceftaroline 5-μg disk.
    Koeth LM; Matuschek E; Kahlmeter G; Alm RA; Ambler JE
    Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1511-7. PubMed ID: 24744220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro activity of ceftaroline to MRSA isolates: a multicenter study].
    Mengeloğlu FZ; Taş T; Koçoğlu E; Copur Çiçek A; Yanık K; Güneş H; Ciftci IH; Durmaz S; Bucak O; Güçkan R; Terzi HA; Yavuz MZ
    Mikrobiyol Bul; 2013 Oct; 47(4):677-83. PubMed ID: 24237436
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Gaikwad V; Gohel T; Panickar S; Chincholkar V; Mangalkar S
    Indian J Pathol Microbiol; 2016; 59(4):496-498. PubMed ID: 27721280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program.
    Sader HS; Flamm RK; Farrell DJ; Jones RN
    Clin Infect Dis; 2012 Sep; 55 Suppl 3():S181-6. PubMed ID: 22903950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.